Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
US Musckoloskeletal Device & Implant Market to Grow11.8% by 2012
Jan 21, 2009
The US musckoloskeletal device and implant market was valued at more than US$ 20 Billion in 2008, making up for over 50% of the global market for such devices, according to “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US”, a new research report from RNCOS. The market is projected to see a blistering CAGR growth of 11.8% through 2012.
The reconstructive surgery segment, representing 33.5% of the musculoskeletal device and implant market, is expected to be the key booster to the US musculoskeletal device & implant market in the next four years, with Spinal (30.7%) and Fixation (16.0%) playing secondary role in the growth, anticipates the report.
Re-constructive joint implants are likely to continue to represent the largest segment in the reconstructive surgery field primarily due to rising demand for more procedures by increasing elderly population. The positive outlook for joint implants segment is based on figures of 2007 when nearly 663,000 knee replacement procedures and 251,000 hip replacement procedures were successfully performed, according to the report. Further, the number of both hip and knee replacement procedures is expected to surge sharply by 2012, with increasing incidents of knee and hip fractures and decreasing relevance of patients’ age profile. Patients are opting for such procedures at a much younger age now while earlier they were chosen at much older age.
“Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US” discusses the past, current and future market scenario by providing factual details along with quality statistical data. The report gives insight into the structure, composition and working of the US healthcare sector and discusses hospital services, pharmaceuticals and medical devices available in the market.
Besides, it contains information on demand, market size and future prospects of all major US healthcare segments such as cardiovascular, in vitro diagnostics, diabetes, dental health, musculoskeletal, cosmetic surgery, oncology and wound care management. It will help the clients to understand key opportunities and challenges that will guide the market in future.
The research study provides forecast on factors like cancer surgery market, biotechnology-based cancer drug market, wound care product market, osteoporosis & low bone mass patients, hip replacement procedures, knee replacement procedures and cardiovascular diseases, and stroke expenditure by type.
For more information visit: http://www.rncos.com/Report/IM147.htm
Some of our Related Reports are as follows:Â
Related Releases are as follows:
- Green Go to Derma Clinical Trial - How will it Shape Industry?
- Liquid Biopsy Paving the Way to Growth through Strategic Transactions
- India- A Largely Untapped Market for NIPT
- Government Initiatives Promoting the Indian Healthcare Sector
- Clinical Chemistry Testing Major Driver for US Clinical Laboratory Testing Market
Media Citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2014, RNCOS, 2002-2014
About Us
Terms & Policy
Contact